| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Biohaven Ltd. | SVP, Clinical Operations | Common Shares | 97.8K | $3.78M | $38.64 | Jan 5, 2025 | Direct |
| Biohaven Ltd. | SVP, Clinical Operations | Stock Options (Right to buy) | 91K | Jan 5, 2025 | Direct | ||
| Biohaven Ltd. | SVP, Clinical Operations | Restricted Share Unit Award | 11.3K | Jan 5, 2025 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | SVP, Clinical Operations | Common Shares | 0 | Oct 3, 2022 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | SVP, Clinical Operations | Restricted Share Unit Award | 0 | Oct 3, 2022 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | SVP, Clinical Operations | Stock Options (Right to Buy) | 0 | Oct 3, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | Jan 5, 2025 | 5 | -$75.6K | 4 | Jan 7, 2025 | SVP, Clinical Operations |
| BHVN | Biohaven Ltd. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | SVP, Clinical Operations |
| BHVN | Biohaven Ltd. | Nov 2, 2023 | 1 | $0 | 4 | Nov 6, 2023 | SVP, Clinical Operations |
| BHVN | Biohaven Ltd. | Oct 3, 2022 | 42 | $18.7K | 4 | Oct 5, 2022 | SVP, Clinical Operations |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Oct 3, 2022 | 16 | -$1.73M | 4 | Oct 3, 2022 | SVP, Clinical Operations |
| BHVN | Biohaven Ltd. | Sep 28, 2022 | 0 | $0 | 3 | Sep 30, 2022 | SVP, Clinical Operations |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Jan 6, 2022 | 5 | -$223K | 4 | Jan 7, 2022 | SVP, Clinical Operations |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Nov 25, 2021 | 3 | -$201K | 4 | Nov 26, 2021 | SVP, Clinical Operations |